Financial Services · Biotechnology
HepaRegeniX news and milestones
HepaRegeniX: 17 headlines on record, 6 headlines in the last 90 days. Its story counts 4 milestones.
Data updated Nov 17, 2026 · Back to the company report
17Headlines
6In 90 days
4Milestones
Headlines
Sep 222026
News · markets.businessinsider.com
HepaRegeniX to seamlessly advance darizmetinib's clinical development to Phase 2a following completion of the Phase 1b in 2026Tuebingen, Germany, ...
Aug 262026
News · markets.businessinsider.com
U.S. FDA Orphan Drug Designation underscores darizmetinib's potential to address a significant unmet need following liver resection Tuebingen, Ger...
May 132026
Blog
Tuebingen, Germany, May 13, 2026 - HepaRegeniX GmbH ("HepaRegeniX"), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, announces th…
Feb 112026
Blog
Tuebingen, Germany, February 11, 2026 - HepaRegeniX GmbH ("HepaRegeniX"), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, today a…
Jun 10, 20252025
Blog
Tuebingen, Germany, June 10, 2025 - HepaRegeniX GmbH ("HepaRegeniX"), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced…
May 8, 20252025
Blog
Prof. Lars Zender's featured talk described HepaRegeniX's lead candidate and its potential in increasing liver regeneration, from initial target discovery and drug development to…
Apr 15, 20252025
Blog
Tuebingen, Germany, April 15, 2025 - HepaRegeniX GmbH ("HepaRegeniX"), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announc…
Oct 22, 20242024
Blog
Elias Papatheodorou moves from Chair of Board to CEO and Managing Director of HepaRegeniX Preparations for upcoming clinical trials in the USA are ongoing Tuebingen (Germany), Oc…
Jul 10, 20242024
Press release
Tuebingen (Germany), July 10, 2024 - HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases…
Mar 15, 20242024
Blog
Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, researchers from the Mayo Clinic in Rochester (USA) and HepaRegeniX HRX-21…
Sources: the outlets named on each headline, each story once
Milestones
Oct 22, 2024
Jul 10, 2024
2016
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
HepaRegeniX, News. Alion, Nov 17, 2026. https://alion.io/company/heparegenix/news
